Table 2 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging assay of dibutylstannanediyl bis(4-((4-nitrophenyl)amino)-4-oxobut-2-enoate (DTN) and ascorbic acid
From: Pharmacological evaluation of newly synthesized organotin IV complex for antiulcer potential
Samples | Concentration (μg/mL) | % DPPH inhibition (Mean ± SEM) | IC50 (μg/mL) |
|---|---|---|---|
DTN | 200 | 70.13 ± 0.57 | 7.4 |
66.6 | 60.27 ± 1.15 | ||
22.2 | 57.83 ± 0.28 | ||
7.4 | 44.32 ± 0.18 | ||
2.46 | 42 ± 0.46 | ||
Ascorbic acid | 20 | 88 ± 0.55 | 4.3 |